Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 1 Published - 14:00 UTC    08:00 EST    23-May-2000      
Issue 40 Next Update - 14:00 UTC 08:00 EST    24-May-2000      

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya

Back To Vidyya Lower Your Cholesterol, Lose Your Mind

Lovastatin Exhibits Small, Deliterious, Effects On Cognitive Function

Two new studies published in the May issue of The American Journal of Medicine show that cholesterol lowering results in minor impairments in one or more aspects of cognitive function, but has no detectable effects on mood.

In the first report, Dr. Matthew F. Muldoon, of the University of Pittsburgh, in Pennsylvania, and colleagues explain that previous cross-sectional and animal studies have shown that changes in serum lipid concentrations may influence aspects of behavior, mood and cognitive function. They note, however, that few clinical trials have addressed these effects.

Their aim in the present study was to determine the psychological effects of lovastatin treatment for hypercholesterolemia. To this end, the study team randomized 209 healthy adults, with LDL cholesterol levels of at least 160 mg/dL, to 6-month therapy with 20 mg/day lovastatin or placebo, and assessed cognitive function and psychological well-being at the beginning and end of the treatment period.

The authors report that placebo-treated patients showed improvements in all five of the administered neuropsychological tests over the treatment period, which was "consistent with the effects of practice on test performance." In contrast, lovastatin-treated participants only showed improvements in the memory-recall test.

When compared with placebo, the researchers observed significant, but small, deleterious effects of lovastatin treatment on measures of psychomotor speed and attention. In lovastatin-treated individuals, alterations in performance tests for mental flexibility, working memory and memory recall were not found to be statistically significant.

They conclude that psychological well-being was not affected by lovastatin. However, Dr. Muldoon's group speculates that because "lovastatin causes small decrements in scores on tests of psychomotor speed and attention....[it] could affect performance on tasks, such as automobile driving, which require the integration of a broad array of cognitive abilities."

In the second report, Dr. Jane Wardle, of the University London, UK and colleagues randomly assigned 176 patients to a low-fat diet, a Mediterranean diet or to a waiting-list control. They determined cholesterol levels, psychological well-being and cognitive function at baseline and at 6 and 12 weeks.

The authors note that both dietary interventions successfully reduced serum cholesterol levels. They also observe that all three cohorts showed similar improvements in psychological well-being over the treatment period, which they suggest may have been due to increased levels of attention and support during the study.

"There were no between-group differences on three measures of cognitive function, but for a fourth measure, which involved the task with the greatest processing load, the two intervention groups did significantly worse," they report.

The investigators point out that the cognitive impairment in the two intervention groups was most marked in patients with the largest decline in serum cholesterol.

In light of their findings, Dr. Wardle's group concludes that the adverse effect of lowering cholesterol on the single aspect of cognitive function warrants further study. "If the effect proves to be robust, its explanation will need to be determined," they conclude.

Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 

Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.